3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Neoplasms
1
Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Advanced Head and Neck Carcinoma
1
Interventions
Nivolumab
11
Specimen Handling
8
Ipilimumab
7
pembrolizumab
5
CTLA-4 Antigen
5
cabozantinib
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
Radiosurgery
3
Axitinib
3
pazopanib
2
Sunitinib
2
Everolimus
2
Blood Specimen Collection
2
tivozanib
1
sodium-iodide symporter
1
sitravatinib
1
lenvatinib
1
belzutifan
1
aldesleukin
1
Zoledronic Acid
1
Tissue Banks
1
Selenomethionine
1
Radiotherapy
1
Radiopharmaceuticals
1
Nephrectomy
1
Molecular Imaging
1
Metastasectomy
1
Inulin
1
Interleukin-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Clear-cell metastatic renal cell carcinoma
×
Radiopharmaceuticals
×
Clear all
NCT06059014
2026-04-24
PRadR
Centre Leon Berard
Phase 1/2
Completed
6 enrolled